PMA device
Prosorba Column
Fresenius Hemocare, Inc. · Separator, Automated, Blood Cell And Plasma, Therapeutic (LKN, Unclassified) · First FDA decision Oct 26, 2001, newest Apr 14, 2004Anemia, clotting and blood disorders
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
3
PMA pathway
Device trials
0
Naming "Prosorba Column"
MAUDE reports
0
Brand "Prosorba Column", since 2015
PubMed studies
19
Mentioning "Prosorba Column"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Prosorba Column
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 3 of 3 decisions filed under this name.
- PROSORBA COLUMNPMA supplement
P850020-S019 · Decided Apr 14, 2004 · 180 days after receipt · Normal 180 Day Track No User Fee
Device type: Separator, automated, blood cell and plasma, therapeutic (LKN) · GI, Urology & Nephrology
- PROSORBA COLUMNPMA supplement
P850020-S016 · Decided Feb 12, 2003 · 180 days after receipt · Normal 180 Day Track
Device type: Separator, automated, blood cell and plasma, therapeutic (LKN) · GI, Urology & Nephrology
- PROSORBA COLUMNPMA supplement
P850020-S013 · Decided Oct 26, 2001 · 179 days after receipt · Normal 180 Day Track
Device type: Separator, automated, blood cell and plasma, therapeutic (LKN) · GI, Urology & Nephrology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Prosorba Column", any status and sponsor, newest update first.
No registered device study names "Prosorba Column".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Prosorba Column", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code LKN
1,471 reports: 891 malfunction, 496 injury, 79 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-1086-03 · Started Jul 11, 2003 · Posted by FDA Aug 6, 2003
Reason given: No package insert
Cause as FDA categorized it: Other · Device type: Columns, Immunoadsorption In Extracorporeal Systems (LQQ)
Published research
The most relevant PubMed records for "Prosorba Column"[tiab]. The summary above synthesizes these.
- Protein A-immunoadsorption (Prosorba column) in the treatment of rheumatoid arthritis.
Poullin P, Announ N, Mugnier B, et al. · Joint Bone Spine · 2005Editorial, Review
- A randomized double-blind sham-controlled trial of the Prosorba column for treatment of refractory rheumatoid arthritis.
Gendreau RM · Ther Apher · 2001Clinical Trial, Clinical Trial, Phase III
- Immunoglobulin binding properties of the Prosorba immunadsorption column in treatment of rheumatoid arthritis.
Sasso EH, Merrill C, Furst TE · Ther Apher · 2001Clinical Trial, Clinical Trial, Phase III
- Recent advances in therapeutic apheresis.
Bosch T · J Artif Organs · 2003Review
- The Prosorba column for treatment of refractory rheumatoid arthritis: a randomized, double-blind, sham-controlled trial.
Felson DT, LaValley MP, Baldassare AR, et al. · Arthritis Rheum · 1999Clinical Trial, Multicenter Study
- Vasculitis secondary to staphylococcal Protein A immunoadsorption (Prosorba column) treatment in rheumatoid arthritis.
Deodhar A, Allen E, Daoud K, et al. · Semin Arthritis Rheum · 2002Case Reports
- Correcting immune imbalance: the use of Prosorba column treatment for immune disorders.
Levy J, Degani N · Ther Apher Dial · 2003Review
- Toxicity following protein A treatment of metastatic breast adenocarcinoma.
Ainsworth SK, Pilia PA, Pepkowitz SH, et al. · Cancer · 1988Clinical Trial, Randomized Controlled Trial
- Cost-effectiveness of Prosorba column therapy for rheumatoid arthritis: a framework for analysis.
Griffiths RI, Slurzberg JE · Ther Apher · 2001
- Effects of Prosorba column apheresis in patients with chronic refractory rheumatoid arthritis.
Roth S · J Rheumatol · 2004Clinical Trial, Clinical Trial, Phase IV
- Prosorba column for rheumatoid arthritis.
Med Lett Drugs Ther · 1999
- Treatment of patients with HIV thrombocytopenia and hemolytic uremic syndrome with protein A (Prosorba column) immunoadsorption.
Mittelman A, Bertram J, Henry DH, et al. · Semin Hematol · 1989
Other devices of this type
Also filed under product code LKN.
- Prosorba Protein a Immunoadsorption ColumnFresenius Hemocare, Inc. · PMA 2005
- Spectra Optia Apheresis SystemTerumobct, Inc. · 510(k) 2019
- Amicus Separator System/ Amicus Seperator SystemFenwal, Inc. · 510(k) 2014
- AMICUS Separator SystemFresenius Kabi AG · 510(k) 2019
- AMICUS Separator SystemFresenius Kabi USA,Llc · 510(k) 2018
- Spectra Optia Apheresis SystemTerumo Bct · 510(k) 2015
- Spectra Optia Apheresis SystemCaridianbct, Inc.. · 510(k) 2012
- Spectra Optia R Apheresis SystemCaridianbct, Inc.. · 510(k) 2010
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.